Literature DB >> 27196033

Cyclization of 4-Phenoxy-2-coumarins and 2-Pyrones via a Double C-H Activation.

Katrina Mackey1, Leticia M Pardo1, Aisling M Prendergast1, Marie-T Nolan1, Lorraine M Bateman1, Gerard P McGlacken1.   

Abstract

Aryl-heteroaryl coupling via double C-H activation is a powerful transformation that avoids the installation of activating groups. A double C-H activation of privileged biological scaffolds, 2-coumarins and 2-pyrones, is reported. Despite the rich chemistry of these molecular frameworks, the yields are very good. Excellent regioselectivity was achieved on the pyrones. This methodology was applied to the synthesis of flemichapparin C in three steps. Isotope effect experiments were carried out, and a mechanism is proposed.

Entities:  

Year:  2016        PMID: 27196033     DOI: 10.1021/acs.orglett.6b00751

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  One-pot two-step synthesis of 3-iodo-4-aryloxy coumarins and their Pd/C-catalyzed annulation to coumestans.

Authors:  Niranjan Panda; Irshad Mattan
Journal:  RSC Adv       Date:  2018-02-16       Impact factor: 4.036

2.  A Novel Non-Peptidic Agonist of the Ghrelin Receptor with Orexigenic Activity In vivo.

Authors:  Elena Pastor-Cavada; Leticia M Pardo; Dalia Kandil; Cristina Torres-Fuentes; Sarah L Clarke; Hamdy Shaban; Gerard P McGlacken; Harriet Schellekens
Journal:  Sci Rep       Date:  2016-11-07       Impact factor: 4.379

3.  Pyran Rings Containing Polyketides from Penicillium raistrickii.

Authors:  Li-Ying Ma; De-Sheng Liu; De-Guo Li; Yu-Ling Huang; Hui-Hui Kang; Chun-Hua Wang; Wei-Zhong Liu
Journal:  Mar Drugs       Date:  2016-12-23       Impact factor: 5.118

4.  Copper-catalyzed intramolecular cross dehydrogenative coupling approach to coumestans from 2'-hydroxyl-3-arylcoumarins.

Authors:  Xianheng Song; Xiang Luo; Jianfei Sheng; Jianheng Li; Zefeng Zhu; Zhibo Du; Hui Miao; Meng Yan; Mingkang Li; Yong Zou
Journal:  RSC Adv       Date:  2019-06-03       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.